SKYLJIX
LIVE

Serial Number

79256576

Owner

NOVARTIS AG

Filing Date

Feb 8, 2019

Add to watchlist:

No watchlists yet
View on USPTO

SKYLJIX Trademark

Serial Number: 79256576 • Registration: 5841911

SKYLJIX is a trademark filed by NOVARTIS AG on February 8, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,171 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

February 8, 2019

Registration Date

August 27, 2019

Published for Opposition

June 11, 2019

Cancellation Date

March 13, 2026

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

CANCELLED SECTION 71
Mar 13, 2026 C71T
NOTIFICATION PROCESSED BY IB
Oct 18, 2019 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Oct 2, 2019 FICS
FINAL DISPOSITION PROCESSED
Oct 2, 2019 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Sep 26, 2019 GPAR
REGISTERED-PRINCIPAL REGISTER
Aug 27, 2019 R.PR
PUBLISHED FOR OPPOSITION
Jun 11, 2019 PUBO
NOTICE OF PUBLICATION
May 22, 2019 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 6, 2019 CNSA
APPLICATION FILING RECEIPT MAILED
May 4, 2019 MAFR
ASSIGNED TO EXAMINER
Apr 30, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 30, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Apr 29, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 18, 2019 REPR